05-AUG-C-9

 

MARY ANNE BEEBE’S INVITATION TO PARTICIPATE

IN HER DOCTORAL DISSERTATION THESIS RESEARCH ON “KNOWLEDGE MAPPING” FOR ONCOLOGISTS,

AND MY DISCLAIMERS BEFORE AGREEING

TO PARTICIPATE

 

August 31, 2005

 

Yes, I should be available either of the dates Oct. 22 or 23, and might suggest Sunday afternoon on the 23rd for the second session.

 

You might come over for the informal part and then we will get as formal as you would like wherever you wish! 

 

I have a very long track record with Merck, which we can compare, since I was the head of their "surgical faculty" which I helped to found.  Elliott Margolis, MD was the in-house CME guru at that time and I knew most of your training and education types--especially all of the MSA's in several of the specialities--ID, and Education especially.  Jeannie Regnante who was the local DM here in DC was on the fast track and after going to HQ I heard last was being moved over from Astra.  I still associate regularly with many of the specialty reps as they go through whatever perturbations of the new marketing, since I had a hand in formulating a few of the "arm's length policies" when I had lectured in my late MSD friend Wayne Ebrite's Johns Hopkins classes.  We can compare names and decades of rapid changes when we "do lunch."

 

I am eager to see you move forward with your dissertation research phase since I will be following closely behind you as I am now in the "first cuts" of formulating the process of my own ideas of transformational leaning experiences among the students I carry with me to the remote parts of the developing world (a couple of short drafts are attached.)

 

I look forward to participating as an "inside outsider!"

 

Cheers!

 

GWG

 

 

 

>>> "Beebe-Ally, Maryann" <maryann_beebe@merck.com> 8/30/2005 4:04 PM >>>

Dear Dr. Geelhoed,

 

I am happy to set our first meeting for Saturday, Sept. 17 around 1:00 pm!

 

For our second meeting, would October 22 or 23 work in your schedule? 

 

I like the idea of visiting before our meeting starts.  Would you accept my

invitation to meet for lunch at a local restaurant prior to our 1:00 working

session?  We can compare notes about our experiences in the cohort program!

Your offer to have the meeting in your home is most generous.  I think I

would feel too comfortable in a home setting.  The Boardroom provides an

atmosphere that is conducive to formal data collection. 

 

Over our lunch together I would be interested in your experiences with

Merck, if that is not too personal.  I remember you saying that you

partnered with Merck for some international initiative in antibiotics.  I

like talking about industry related things.

 

Merck paid for my MBA and my first doctorate, so I guess they thought that

was enough.  My boss said my work was top notch and I did not need further

education.  I really wanted to participate in this Ed.D. program so I

decided to pay for it myself.

 

I look forward to your confirmation about lunch and location on Sept. 17 as

well as your availability on either Oct. 22 or 23.

 

All the best,

Maryann

 

 

-----Original Message-----

From: Glenn Geelhoed [mailto:msdgwg@gwumc.edu]

Sent: Tuesday, August 30, 2005 2:58 PM

To: maryann_beebe@merck.com

Subject: RE: Invitation to participate in an oncologist research initiative

e e

 

 

OK--let's start with the first of the first sessions--Saturday Sept 17

after your meeting with Dave Schwandt.  I may propose something even

better than the Hampton Inn conference room under the assumption that

you will be checking out and driving back to Pennsylvania--since you

could come up 270 and pop on over to my home.  Someone should be using

it as often as I leave it vacant on my frequent travel schedule!

 

I will attach directions.  I can also meet anywhere along the way, but

this may make it possible for us to visit a little around your

interview.

 

The second is a non-starter which I had listed in the letter I had

posted to you since I will be gone the evening of the ELDP weekend in

October and in a remote part of Colorado during that interval.  But, I

will try to arrange whatever else may work for an alternative.

 

I was impressed with your disclosure statement since I know Merck

rather well, but did not know that they were not sponsoring your EdD

ELDP program.  Shame on them for not doing so!

That makes both you AND your next degree portable!

 

I will work out further details of our second session as you can

arrange it.

 

Cheers! 

 

GWG

>>> "Beebe-Ally, Maryann" <maryann_beebe@merck.com> 8/30/2005 1:49 PM

>>> 

Dear Dr. Geelhoed,

 

You are impressive!  Thanks for being so proactive with the informed

consent.  You are a step ahead!

 

I am glad you saw Skip.  He has been a great person on my dissertation

committee.  He will undoubtedly be a strong advocate for your work.

 

Let's pick dates!  I can propose something, but please feel free to

make

counter suggestions that best fit your schedule.

 

          1st Session (1-1/2 hours)

          Saturday, Sept. 17 at 1:00 pm; or

          Sunday, Sept. 18 at 9:30 am

          These are just proposed times; there is flexibility anytime the

afternoon of Sept 17 or the morning of Sept 18

          I have an appointment with Dr. Schwandt on Saturday, Sept. 17

at

10:00 am.

 

Location:  The Hampton Inn in Sterling, VA (where the out-of-town

cohort

members stay) has a Boardroom where we can meet.  

 

Hampton Inn

46331 McClellan Way

Sterling, VA 20165

703-450-9595

 

          2nd Session (2 hours)

          Saturday, Oct. 15 at 1:00 pm; or

          Sunday, Oct. 16 at 9:30 am

          These are just proposed times; there is flexibility anytime the

afternoon of Oct. 15 or the morning of Oct. 16.

 

I look forward to hearing your comments on what works best in your

schedule.

 

Appreciatively,

Maryann

 

 

-----Original Message-----

From: Glenn Geelhoed [mailto:msdgwg@gwumc.edu]

Sent: Tuesday, August 30, 2005 12:39 PM

To: maryann_beebe@merck.com

Subject: RE: Invitation to participate in an oncologist research

initiative

e

 

 

I have already signed and dated and mailed the consent form back to

you!

 I was dropping it in the post when I had bumped into Skip, so I also

mentioned to him both my disclaimers and eagerness to help you in your

dissertation data gathering.  He will be on my committee also.

 

I will arrange whatever timing works for you!

 

GWG

 

>>> "Beebe-Ally, Maryann" <maryann_beebe@merck.com> 8/30/2005 11:54 AM

>>> 

Dear Dr. Geelhoed,

 

I am humbled and delighted that you are willing to participate!

 

I double-checked the wording in my dissertation about my inclusion

criteria.

Luck is on my side because I did not specify medical or surgical

oncologist

in the text (although medical oncologist was what I was thinking at

the

time).  I believe your experience as a surgeon, your rich and diverse

experience, and your work in a teaching hospital setting will add an

element

to the data that would be missing without you. 

 

Let us proceed!  Enclosed is an invitation/confirmation letter about

the

study as well as the informed consent form.  As the letter describes

on

the

second page, I look forward to hearing about the dates that work best

in

your schedule.

 

All the best,

Maryann

 

 

-----Original Message-----

From: Glenn Geelhoed [mailto:msdgwg@gwumc.edu]

Sent: Tuesday, August 30, 2005 10:12 AM

To: maryann_beebe@merck.com

Subject: Re: Invitation to participate in an oncologist research

initiative

 

 

The pleasure, Wonder Woman, would be all mine!

 

First, you should have the disclaimer as my "un-qualifier."  I am not

now a card-carrying Oncologist of the "Heme-Onc" sort, and although I

once belonged to ACOG and SWOG etc, I do not now regularly attend such

events.  I am, and always have been a Surgical Oncologist, as

reflected

by my membership in the SOS (Surgical Oncology Society, formerly the

Ewing Society) and had been an active associate of the Surgery Branch

of

the National Cancer Institute for Five Years.  When full time in the

Surgery Department at GWU I headed up several Oncology protocols,

continuing my position as the Head of the Surgical Breast Oncology

Division at NCI.  However, I am not now operating AT GWU but

everywhere

world-wide, as evidenced by what you had recently received from my

expedition to Asmara Eritrea.  I teach the surgical component of

Oncology (I have a book for Board Preparation. entitled "The Study of

Surgery"--which you can Google or Amazon to check out) but, I do what

needs doing for citizens of the developing world (the most recent book

is "Surgery and Healing in the Developing World," Landes BioScience

which you can also Google up or see the attached note.

 

Given all these qualifiers (or exclusion criteria) if you are judging

the credentialing for my inclusion or "outlier status" for

exclusion--I

am surely unique among your choices--I am wiling to participate to

help

you along in the same process I will be following a year behind you

into

dissertation stage!

 

Let me know if I have prejudiced myself out of your further

consideration, or whether the intrigue continues!

 

Cheers!

 

GWG 

 

>>> "Beebe-Ally, Maryann" <maryann_beebe@merck.com> 8/29/2005 7:00 PM

>>> 

Dear Dr. Geelhoed,

 

It was a pleasure getting reacquainted with you at the recent Cohort

15/16

weekend.  You have an impressive array of medical specialty expertise

on

your business card. 

 

In follow-up to our conversation during the break at the celebration,

I

would like to officially invite you to be a participant in a

phenomenological research initiative looking at how oncologists make

sense

of professional/organizational competing values.  You meet the

inclusion

criteria of being an oncologist working in a teaching hospital for

more

than

one year.  You will also be making an important contribution to the

social

sciences.

 

If you agree to participate, we would meet twice in person.  The first

time

will be for an in-depth interview lasting approximately 90 minutes.

The

second meeting is a working session lasting up to 2 hours.  Your

personal

information will be kept confidential as you will assign a pseudo name

for

yourself. 

 

The purpose of the first session is to talk about two different

situations

you have been in that were important, professional situations where

the

trade-offs among the alternatives were difficult.  Before our second

meeting

my job is to create a knowledge map that illustrates the process of

each

scenario.  In the second meeting you critique the knowledge maps so

that if

I did not accurately represent something it can be corrected, or if

something needs more elaboration it can be included.  In

phenomenological

research, I will then look at the knowledge maps you and the others

provide

to find the common structure of the lived experience, as well as

similarities and variances among them.

 

It would be an honor to have the richness of your experiences included

in

this study.  I would like to re-emphasize that your personal

information

will be kept confidential. 

 

May I have the pleasure of including you in the study?

 

Best regards,

Maryann

 

908-423-4383 work

610-997-3944 home

 

 

 

 

----------------------------------------------------------------------------

--

Notice:  This e-mail message, together with any attachments, contains

information of Merck & Co., Inc. (One Merck Drive, Whitehouse Station,

New Jersey, USA 08889), and/or its affiliates (which may be known

outside the United States as Merck Frosst, Merck Sharp & Dohme or MSD

and in Japan, as Banyu) that may be confidential, proprietary

copyrighted and/or legally privileged. It is intended solely for the

use

of the individual or entity named on this message.  If you are not the

intended recipient, and have received this message in error, please

notify us immediately by reply e-mail and then delete it from your

system.

----------------------------------------------------------------------------

--

 

 

 

 

 

----------------------------------------------------------------------------

--

Notice:  This e-mail message, together with any attachments, contains

information of Merck & Co., Inc. (One Merck Drive, Whitehouse Station,

New Jersey, USA 08889), and/or its affiliates (which may be known

outside the United States as Merck Frosst, Merck Sharp & Dohme or MSD

and in Japan, as Banyu) that may be confidential, proprietary

copyrighted and/or legally privileged. It is intended solely for the use

of the individual or entity named on this message.  If you are not the

intended recipient, and have received this message in error, please

notify us immediately by reply e-mail and then delete it from your

system.

----------------------------------------------------------------------------

--

 

 

 

------------------------------------------------------------------------------

Notice:  This e-mail message, together with any attachments, contains information of Merck & Co., Inc. (One Merck Drive, Whitehouse Station, New Jersey, USA 08889), and/or its affiliates (which may be known outside the United States as Merck Frosst, Merck Sharp & Dohme or MSD and in Japan, as Banyu) that may be confidential, proprietary copyrighted and/or legally privileged. It is intended solely for the use of the individual or entity named on this message.  If you are not the intended recipient, and have received this message in error, please notify us immediately by reply e-mail and then delete it from your system.

------------------------------------------------------------------------------